The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for vorasidenib citrate (Servier Laboratories (Aust) Pty Ltd)
Active ingredients
vorasidenib citrate
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Immediate release, film coated tablet
Indication
Treatment of IDH-mutant diffuse glioma
Therapeutic area
Oncology